Fundraising Fox

Adarx

Founded 2019 · 100 employees on LinkedIn · 7 known investors

ADARx is a clinical-stage biotechnology company developing RNA-targeted therapeutics designed to control the expression of disease-driving genes. It focuses on treatments for a range of diseases with unmet medical needs.

BiotechHealthtechMedical Devices

Founders & leadership

Adarx was founded in 2019 by Zhen Li and Rui Zhu.

ZL
Zhen LiinCo-founder, President & CEO
RZRui Zhu
Rui ZhuFounding Member & Chief Technology Officer
RARob Ackles
Rob AcklesinChief People Officer
RFRyan Fisk
Ryan FiskinChief Financial Officer & Chief Business Officer
RARobert A. MacLeod
Robert A. MacLeodinChief Scientific Officer
CC
Christopher ClaeboeinSenior Vice President of Operations

Investors · 7

OrbiMed✓ verifiedNew York · $1M – $75M
Bain Capital Life Sciences✓ verifiedBoston
Lilly Asia Ventures✓ verifiedHong Kong
SR One Capital Management✓ verifiedRedwood City
T. Rowe Price✓ verifiedBaltimore
TCG CrossoverPalo Alto
Vivo CapitalPalo Alto · $10M – $50M

Frequently asked questions

What does Adarx do?
ADARx is a clinical-stage biotechnology company developing RNA-targeted therapeutics designed to control the expression of disease-driving genes. It focuses on treatments for a range of diseases with unmet medical needs.
Who founded Adarx?
Adarx was founded by Zhen Li, Rui Zhu in 2019.
Who are Adarx's investors?
Adarx's investors include OrbiMed, Bain Capital Life Sciences, Lilly Asia Ventures, SR One Capital Management, T. Rowe Price, TCG Crossover, Vivo Capital.